1992: PhD in Organic Chemistry, Technical University of Munich, group of Prof. Horst Kessler, on antiadhesive RGD peptides and peptidomimetics
1992-1994 Glaxo Verona
1994-2001 Bayer AG, Leverkusen, different Med Chem and Project Management assignmts.
2001-2003 Organon, Netherlands, Section Head Lead Finding
2003-2005 CSO at Axxima Pharmaceuticals
2005-2008 VP Drug Discovery at GPC Biotech AG
2008-2011 CSO Proteros Fragments
Since beg 2011: Senior Vice President Med Chem at Mercachem
Medicinal Chemistry Services within 'small pharma':
from molecular understanding to complex chemistry
Within 'small' medicinal chemistry focused companies it is mandatory to elaborate and mature research topics into novel offerings that anticipate the tomorrow’s needs of 'big pharma'. In this context, the privileged structure concept aiming at therapeutically relevant target families will be introduced with emphasis laid on the required three-dimensionality of novel compounds.